We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
- Authors
Voors, Adriaan A; Davison, Beth A; Teerlink, John R; Felker, G Michael; Cotter, Gad; Filippatos, Gerasimos; Greenberg, Barry H; Pang, Peter S; Levin, Bruce; Hua, Tsushung A; Severin, Thomas; Ponikowski, Piotr; Metra, Marco; RELAX-AHF Investigators
- Abstract
<bold>Aims: </bold>We studied the characteristics and clinical outcome related to diuretic response and the effects of serelaxin in patients hospitalized for acute heart failure (AHF).<bold>Methods and Results: </bold>RELAX-AHF was a double-blind, placebo-controlled trial, enrolling 1161 patients admitted to hospital for AHF who were randomized to 48 h i.v infusions of placebo or serelaxin (30 µg/kg per day) within 16 h from presentation. Diuretic response was defined as Δ weight kg/[(total i.v. dose)/40 mg] + [(total oral dose)/80 mg)] furosemide (or equivalent loop diuretic dose) up to day 5. Median diuretic response was -0.42 (-1.00, -0.14) kg/40 mg. A poor diuretic response was independently associated with Western-like region (Western Europe, North America, Israel, and Poland), lower diastolic blood pressure, the absence of oedema, higher blood urea nitrogen, and lower levels of aspartate aminotransferase and potassium (all P < 0.01). Randomization to serelaxin was associated with lower doses of i.v. loop diuretics and slightly less weight loss, resulting in a neutral effect on diuretic response. Worse diuretic response was independently associated both with less relief of dyspnoea, measured with a visual analogue scale (VAS) at day 5 (primary endpoint; P = 0.0002), and with a higher risk of cardiovascular death or rehospitalization for heart failure or renal failure through day 60 (secondary endpoint, P < 0.0001), but not with increased 180-day cardiovascular mortality (P = 0.507).<bold>Conclusions: </bold>In patients hospitalized for AHF, a poor diuretic response was associated with a poor in-hospital and early post-discharge clinical outcome. Serelaxin had a neutral effect on diuretic response.<bold>Trial Registration: </bold>NCT00520806.
- Publication
European Journal of Heart Failure, 2014, Vol 16, Issue 11, p1230
- ISSN
1388-9842
- Publication type
journal article
- DOI
10.1002/ejhf.170